www.fdanews.com/articles/97680-ipca-cdri-to-develop-anti-malarial-drugs-based-on-artemisinin
IPCA, CDRI to Develop Anti-Malarial Drugs Based on Artemisinin
August 27, 2007
Drug maker IPCA Laboratories said together with Central Drug Research Institute (CDRI) it will develop a synthetic substitute of anti-malarial drugs, based on Artemisinin.
The Economic Times